BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33376376)

  • 1. Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis.
    Cabout E; Eymere S; Launois R; Aslanian F; Taïeb C; Seité S
    Clin Cosmet Investig Dermatol; 2020; 13():987-996. PubMed ID: 33376376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis.
    Cabout E; Eymere S; Launois R; Séité S; Delvigne V; Taïeb C; Reguai Z
    Acta Derm Venereol; 2021 Jul; 101(7):adv00509. PubMed ID: 34230978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
    Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
    Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emollients for preventing atopic eczema: Cost-effectiveness analysis of the BEEP trial.
    Sach TH; Lartey ST; Davies C; Chalmers JR; Haines RH; Bradshaw LE; Montgomery AA; Thomas KS; Brown SJ; Ridd MJ; Lawton S; Cork MJ; Flohr C; Mitchell E; Swinden R; Wyatt L; Tarr S; Davies-Jones S; Jay N; Kelleher MM; Perkin MR; Boyle RJ; Williams HC;
    Clin Exp Allergy; 2023 Oct; 53(10):1011-1019. PubMed ID: 37574761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP).
    Tang MB; Leong KF; Ou LS; Munasir Z; Parekh PR; Azmi S; Low WH; Goh A
    J Drugs Dermatol; 2015 Feb; 14(2):169-75. PubMed ID: 25689812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Flares in Children with Atopic Dermatitis with Regular Use of an Emollient Containing Glycerol and Paraffin: A Randomized Controlled Study.
    Tiplica GS; Kaszuba A; Malinauskienė L; Konno P; Boralevi F; Garrigue E; Saint-Aroman M; Delarue A
    Pediatr Dermatol; 2017 May; 34(3):282-289. PubMed ID: 28271540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
    Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden--with model applications for Denmark, Norway and Finland.
    Hjalte F; Asseburg C; Tennvall GR
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):474-80. PubMed ID: 19793150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open-label study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream in combination with regular emollient skin care in reducing the risk of relapse in pediatric patients with stabilized atopic dermatitis.
    Liu L; Ong G
    J Dermatolog Treat; 2018 Aug; 29(5):501-509. PubMed ID: 29164960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M; Garside R; Stein K
    Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention.
    Simpson EL; Chalmers JR; Hanifin JM; Thomas KS; Cork MJ; McLean WH; Brown SJ; Chen Z; Chen Y; Williams HC
    J Allergy Clin Immunol; 2014 Oct; 134(4):818-23. PubMed ID: 25282563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should Emollients Be Recommended for the Prevention of Atopic Dermatitis?-New Evidence and Current State of Knowledge.
    Grześk-Kaczyńska M; Petrus-Halicka J; Kaczyński S; Bartuzi Z; Ukleja-Sokołowska N
    J Clin Med; 2024 Feb; 13(3):. PubMed ID: 38337555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing an Ectoin Containing Emollient for Atopic Dermatitis.
    Hon KL; Kung JS; Ng WGG; Leung TF
    Curr Pediatr Rev; 2019; 15(3):191-195. PubMed ID: 30987568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.
    Chalmers JR; Haines RH; Mitchell EJ; Thomas KS; Brown SJ; Ridd M; Lawton S; Simpson EL; Cork MJ; Sach TH; Bradshaw LE; Montgomery AA; Boyle RJ; Williams HC
    Trials; 2017 Jul; 18(1):343. PubMed ID: 28732519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.
    Berth-Jones J; Damstra RJ; Golsch S; Livden JK; Van Hooteghem O; Allegra F; Parker CA;
    BMJ; 2003 Jun; 326(7403):1367. PubMed ID: 12816824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emollient Acceptability in Childhood Atopic Dermatitis: Not All Emollients are Equal.
    Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
    Curr Pediatr Rev; 2018; 14(2):117-122. PubMed ID: 28578641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.
    Weber TM; Samarin F; Babcock MJ; Filbry A; Rippke F
    J Drugs Dermatol; 2015 May; 14(5):478-85. PubMed ID: 25942666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term emollient therapy improves xerosis in children with atopic dermatitis.
    Boralevi F; Saint Aroman M; Delarue A; Raudsepp H; Kaszuba A; Bylaite M; Tiplica GS
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1456-62. PubMed ID: 24267728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of emollients in atopic dermatitis in children].
    Kamińska E
    Dev Period Med; 2018; 22(4):396-403. PubMed ID: 30636240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.